evaporated in vacuo and the residue was purified by flash column chromatography. Compound 1a 1 (A1: 243 mg, 0.50 mmol; B1: 122 mg, 0.250 mmol) was converted to 1b by method A1 and B1. The crude product was purified by flash column chromatography (CH 2 Cl 2 /MeOH A1: 10:0 → 9:1 → 8:2, B1: 85:15 → 8:2) to yield 1b (A1: 106 mg, 87%; B1: 56 mg, 90%) as a white solid. The spectral data were the same as those described in the literature. R f = 0.14 (CH 2 Cl 2 /MeOH 9:1); 1 Compound 3a 4 (376 mg, 0.500 mmol) was converted to 3b by method A1. Compound 5a 5 (329 mg, 0.500 mmol) was converted to 5b by method A1. 
Compound 1b

S6
Compound 8 (800 mg, 1.55 mmol) was dissolved in dry pyridine (5 mL), Ac 2 O (3.5 mL) was added to the mixture and stirred overnight. The solution was poured into ice-water, diluted with CH 2 Cl 2 and extracted. The organic phase was extracted with diluted acetic acid, water, saturated aqueous NaHCO 3 -solution and then dried over Na 2 SO 4 
89%
Compound 12a (350 mg, 0.500 mmol) was added to the mixture of hexafluoroisopropanol (0.5 mL), BF 3 . Et 2 O (0.2 equiv.) and Et 3 SiH (3.8 equiv., 300 L). After complete conversion of the starting compound (cc. 5 min) the solvent was evaporated in vacuo and the crude product was purified by trituration with dry Et 2 O to yield compound 12b (96 mg, 89%) as a white solid. 18 
Compound 13b
COOH FmocHN
